These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 18321547

  • 1. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ, Poe A, Bloland P, McCollum A, Zhou Z, Shi YP, Ouma P, Otieno K, Vulule J, Escalante A, Udhayakumar V, Slutsker L.
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 3. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
    Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G.
    Am J Trop Med Hyg; 2006 Sep; 75(3):375-80. PubMed ID: 16968909
    [Abstract] [Full Text] [Related]

  • 4. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 5. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA, Mens PF, Schoone GJ, Yusuf A, Mwangi J, Kaniaru S, Omer GA, Schallig HD.
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [Abstract] [Full Text] [Related]

  • 6. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 7. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda.
    Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, Naidoo I, Tibenderana J, Roper C.
    J Infect Dis; 2008 Jun 01; 197(11):1598-604. PubMed ID: 18471065
    [Abstract] [Full Text] [Related]

  • 8. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 Jun 01; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 9. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]

  • 10. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep 01; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F.
    Trop Med Int Health; 2007 Oct 01; 12(10):1164-71. PubMed ID: 17956498
    [Abstract] [Full Text] [Related]

  • 12. Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?
    Nzila A, Ochong E, Nduati E, Gilbert K, Winstanley P, Ward S, Marsh K.
    Trans R Soc Trop Med Hyg; 2005 May 01; 99(5):341-6. PubMed ID: 15780340
    [Abstract] [Full Text] [Related]

  • 13. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec 01; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 14. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?
    Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L.
    Am J Trop Med Hyg; 2008 Sep 01; 79(3):320-30. PubMed ID: 18784222
    [Abstract] [Full Text] [Related]

  • 15. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F, Herrera S, Murrain B, Gutiérrez A, Moreno LA, Manzano M, Muñoz A, Plowe CV.
    Am J Trop Med Hyg; 2007 Sep 01; 77(3):438-43. PubMed ID: 17827356
    [Abstract] [Full Text] [Related]

  • 16. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.
    Am J Trop Med Hyg; 2006 Feb 01; 74(2):198-204. PubMed ID: 16474070
    [Abstract] [Full Text] [Related]

  • 17. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
    Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U.
    J Infect Dis; 2008 Nov 15; 198(10):1545-9. PubMed ID: 18834303
    [Abstract] [Full Text] [Related]

  • 18. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec 15; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 19. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported use of sulfadoxine-pyrimethamine.
    Ojurongbe O, Nguetse CN, Fayemiwo SA, Falade CO, Ojurongbe TA, Thomas BN, Meyer CG, Velavan TP.
    Pathog Glob Health; 2018 Mar 15; 112(2):86-92. PubMed ID: 29318942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.